OR WAIT null SECS
Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.
This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.
Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.
June 17, 2019
Two additional production lines expand Lonza’s HPAPI capacity at Visp, Switzerland facility.
June 07, 2019
Tergus Pharma announced a partnership with Great Point Partners and construction of a new commercial manufacturing facility in North Carolina.
June 06, 2019
European midmarket private equity group, Duke Street, has agreed to acquire Kent Pharmaceuticals and Athlone Laboratories from DCC Vital.
June 02, 2019
A simple, one-part DPI aims to make inhalation drug treatment more accessible and affordable.
Excipients and new processing techniques can make a real difference in the development of highly potent therapies.
Wearable and smart devices allow user-friendly subcutaneous drug delivery.
May 28, 2019
Expanded controlled substance capabilities enables Particle Sciences to develop and manufacture Schedule I–V drugs.
May 20, 2019
Catalent expands gene therapy capabilities with $1.2-billion acquisition of Paragon Bioservices.
May 16, 2019
StarTab from Colorcon was designed to ensure functionality and stability for direct compression tableting.
May 15, 2019
Consider both the device characteristics and the powder properties when developing a DPI combination product.